Institute Professor at the Koch Institute for Integrative Cancer Research at MIT, Philip Sharp says: “‘To personalize cancer care, we must interpret changes in cellular networks or mutations to predict the correct drug combination to use.’ In two studies focusing on a promising class of drugs for lung cancer called EGFR tyrosine kinase inhibitors, researchers have pinpointed new drug targets that could enhance the drugs’ activity. They hope the findings will enable a new approach to personalized cancer care, suggesting specific combinations of drugs that will be most effective for an individual’s cancer.”
It has already been trialed in people and could give us a better way to analyze and stimulate the brain.
ÄIO’s fermentation process creates healthy, sustainable oils and fats by upcycling low-value industry organics.
Even before birth, our brains are taking note of the languages we hear.
Since JWST first glimpsed the Universe, we've entered a new era in understanding the earliest objects in the Universe. What have we learned?
U.S. particle physicists recently recommended a list of major research projects that they hope will receive federal funding.